Literature DB >> 20095217

Collection of equine cord blood and placental tissues in 40 thoroughbred mares.

S Bartholomew1, S D Owens, G L Ferraro, D D Carrade, D J Lara, F A Librach, D L Borjesson, L D Galuppo.   

Abstract

REASONS FOR PERFORMING STUDY: Stem cells derived from umbilical cord tissue (UCT) and umbilical cord blood (UCB) in human subjects and horses can be obtained in a minimally invasive fashion with successful propagation of mesenchymal stem cells (MSCs). Currently there are no detailed protocols documenting a procedure to harvest UCB and UCT safely for equine stem cell propagation. HYPOTHESIS: UCB and UCT could be collected without harm to mare or foal.
OBJECTIVES: To develop a standard and safe method for UCB and UCT collection, and prospectively to compare foal and mare health between groups of animals where tissue was and was not collected.
METHODS: This study was conducted at a Thoroughbred breeding facility in central California in 2008. UCB and UCT were collected from 40 mare and foal pairs. Clinical parameters including time for foal to stand and nurse, time for mare to pass the placenta, and foal haematology data at age 24 h were documented and compared to a control group, consisting of the succeeding 40 mare and foal pairs.
RESULTS: UCB was obtained successfully from 36 of 40 (90%) mares and UCT from 38 of 40 (95%) mares. Bacterial contamination was documented in 6 out of 36 (16.6%) UCB samples. There were no significant differences in time to stand or nurse for foals or time to pass the placenta for mares, between the experimental and control groups. There were no clinically relevant differences identified in haematological data obtained from foals with and without UCB collection.
CONCLUSIONS: UCB and UCT can be harvested safely without harm to mares or foals. POTENTIAL RELEVANCE: UCB and UCT samples collected in an inherently contaminated environment can be successfully disinfected and transported with minimal bacterial overgrowth for use in cell culture to isolate MSCs.

Entities:  

Mesh:

Year:  2009        PMID: 20095217     DOI: 10.2746/042516409x429446

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

1.  Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.

Authors:  Arianna Barbara Lovati; Bruna Corradetti; Anna Lange Consiglio; Camilla Recordati; Elisa Bonacina; Davide Bizzaro; Fausto Cremonesi
Journal:  Vet Res Commun       Date:  2010-12-31       Impact factor: 2.459

2.  Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().

Authors:  Danielle D Carrade; Michael W Lame; Michael S Kent; Kaitlin C Clark; Naomi J Walker; Dori L Borjesson
Journal:  Cell Med       Date:  2012-01-01

3.  Amniotic membrane-derived mesenchymal cells and their conditioned media: potential candidates for uterine regenerative therapy in the horse.

Authors:  Bruna Corradetti; Alessio Correani; Alessio Romaldini; Maria Giovanna Marini; Davide Bizzaro; Claudia Perrini; Fausto Cremonesi; Anna Lange-Consiglio
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.

Authors:  Lélia Bertoni; Thomas Branly; Sandrine Jacquet; Mélanie Desancé; Loïc Desquilbet; Pascaline Rivory; Daniel-Jean Hartmann; Jean-Marie Denoix; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

5.  Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.

Authors:  Danielle Jaqueta Barberini; Natália Pereira Paiva Freitas; Mariana Sartori Magnoni; Leandro Maia; Amanda Jerônimo Listoni; Marta Cristina Heckler; Mateus Jose Sudano; Marjorie Assis Golim; Fernanda da Cruz Landim-Alvarenga; Rogério Martins Amorim
Journal:  Stem Cell Res Ther       Date:  2014-02-21       Impact factor: 6.832

Review 6.  Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues-Origins, Characteristics, Signaling Pathways, and Clinical Trials.

Authors:  Magdalena Kulus; Rafał Sibiak; Katarzyna Stefańska; Maciej Zdun; Maria Wieczorkiewicz; Hanna Piotrowska-Kempisty; Jędrzej M Jaśkowski; Dorota Bukowska; Kornel Ratajczak; Maciej Zabel; Paul Mozdziak; Bartosz Kempisty
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.